Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis

Adenoviral Keratoconjunctivitis Clinical Trial

Official title:

Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04041856
• Other study ID #: farabieyehospital
• Status: Not yet recruiting
• Phase: Phase 1/Phase 2
• Start date: August 23, 2019
• Est. completion date: November 22, 2019

Study information

• Verified date: July 2019
• Source: Farabi Eye Hospital
• Contact: Mohammad Soleimani, professor
• Phone: 00989121096496
• Email: Soleimani_md[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis

Description:

Diagnosed EKC patients will be devided into two groups,first group will undergo povidone-iodine 2% eye drop four times a day and the control group will be treated only by artificial tear drops,they will be examined 3 months later and evaluations and data collections for the final comparison will be done.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: November 22, 2019
• Est. primary completion date: October 22, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 17 Years and older

Eligibility

Inclusion Criteria:

• Patients suspected for viral conjunctivitis

Exclusion Criteria:

• Allergic to iodized materials

• Age under 17

Related Conditions & MeSH terms

• Adenoviral Keratoconjunctivitis
• Keratoconjunctivitis

Intervention

Drug:
• Povidone Ophthalmic
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Farabi Eye Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis	Decreased patient's symptoms	3 months
Primary	Povidone-iodine 2% eye drop	Decreased viral load based on PCR results	3 months